Milestone Scientific Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Milestone Scientific Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 94% of Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 89% of Healthcare companies in United States.
- Tangible Net Worth Ratio: Of every $100 of net worth, $97 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-370.5×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 94% of Healthcare companies in United States.
Cash Locked Ratio
$19For every $100 of sales, $19 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $7 tied up three years earlier.
Less money tied up than 61% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales barely changed
Sales changed by +2% in 3 years, too little to measure extra profit per extra sales.
Asset Productivity Ratio
+2% / -43%In 3 years sales changed by +2% while total assets changed by -43%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-18.5×Operating cash was negative last year, while some debt falls due within a year.
Lower than 53% of Healthcare companies in United States.
Cash Cushion Ratio
+0%Cash, after subtracting all debt, equals 0% of its market value (net cash).
Lower than 67% of Healthcare companies in United States.
Tangible Assets Ratio
99%Of every $100 the company owns, $99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 89% of Healthcare companies in United States.
Tangible Net Worth Ratio
97%Of every $100 of net worth, $97 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 86% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Milestone Scientific Inc. made a loss over the last year. Milestone Scientific Inc. owes $0.58 for every $1 it owns. Milestone Scientific Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossMilestone Scientific Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
8.13The share price is 8.13 times Milestone Scientific Inc.'s book value per share, higher than 83% of Healthcare companies in United States.
Market cap
$28 MThe total market value of all of Milestone Scientific Inc.'s shares at today's price (share price × number of shares), smaller than 80% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$3 MWhat Milestone Scientific Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.04Net worth divided by the number of shares. The share price of $0.31 is 8.1 times this, which is the P/B above.
Return on equity (ROE)
-121.7%Milestone Scientific Inc. lost 121.7% of its shareholders' money over the last year, lower than 76% of Healthcare companies in United States.
Owes vs Owns
0.58×Milestone Scientific Inc. owes $0.58 for every $1 it owns (moderate), higher than 63% of Healthcare companies in United States.
Dividend yield
NoneMilestone Scientific Inc. does not currently pay a dividend.
Revenue growth
+4%Revenue rose 4% in the year to Dec 2025, and grew 1% a year on average over 3 years.
Profit growth
LossMilestone Scientific Inc. made a loss in each of the last two years.
Profit margin
-63.8%Milestone Scientific Inc. lost $64 for every $100 of revenue.
Cash vs debt
Net cashMilestone Scientific Inc. held $0 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Milestone Scientific Inc.: $28 M ÷ $3 M (30 Jun 2026) = 8.1.
What is Milestone Scientific Inc.'s return on equity?
Milestone Scientific Inc. lost 121.7% of its shareholders' money over the last year, lower than 76% of Healthcare companies in United States.
How much does Milestone Scientific Inc. owe compared with what it owns?
Milestone Scientific Inc. owes $0.58 for every $1 it owns (moderate), higher than 63% of Healthcare companies in United States.
Does Milestone Scientific Inc. pay a dividend?
No. Milestone Scientific Inc. does not currently pay a dividend.
Is Milestone Scientific Inc.'s revenue growing?
Revenue rose 4% in the year to Dec 2025, and grew 1% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.